Webinar: Companion Diagnostics and Clinical Development in Oncology: A Statistical Perspective

Webinar: Companion Diagnostics and Clinical Development in Oncology: A Statistical Perspective

Clinical Development of Radiopharmaceuticals a Theranostic Pairs and Dosimetry ConsiderationsПодробнее

Clinical Development of Radiopharmaceuticals a Theranostic Pairs and Dosimetry Considerations

Companion Diagnostics Webinar RecordingПодробнее

Companion Diagnostics Webinar Recording

Statistical considerations in the clinical development of novel cancer therapiesПодробнее

Statistical considerations in the clinical development of novel cancer therapies

Genomenon Pharma Webinar | Genomic Biomarker Selection for Companion Diagnostic DevelopmentПодробнее

Genomenon Pharma Webinar | Genomic Biomarker Selection for Companion Diagnostic Development

IDDI WEBINAR: Design and Analysis of Phase II Trials in OncologyПодробнее

IDDI WEBINAR: Design and Analysis of Phase II Trials in Oncology

Panel Discussion: Co-development of Drugs and Companion DiagnosticsПодробнее

Panel Discussion: Co-development of Drugs and Companion Diagnostics

Planning for Co-development of Companion DiagnosticsПодробнее

Planning for Co-development of Companion Diagnostics

Keynote Presentation: A Regulatory Perspective on Molecular Diagnostic DevicesПодробнее

Keynote Presentation: A Regulatory Perspective on Molecular Diagnostic Devices

Companion Diagnostic Approaches in the Development of Cell and Gene TherapiesПодробнее

Companion Diagnostic Approaches in the Development of Cell and Gene Therapies

Keynote Presentation: Companion Diagnostics: Technical, Clinical and Commercial Challenges with...Подробнее

Keynote Presentation: Companion Diagnostics: Technical, Clinical and Commercial Challenges with...

IDDI WEBINAR: The need for better endpoints: Towards a more efficient drug development in oncologyПодробнее

IDDI WEBINAR: The need for better endpoints: Towards a more efficient drug development in oncology

Thomas Metcalfe-Precision Medicine Approaches and the Future of Drug Development in OncologyПодробнее

Thomas Metcalfe-Precision Medicine Approaches and the Future of Drug Development in Oncology

FDA Guidance on Co-Development of Therapeutics and Companion DiagnosticsПодробнее

FDA Guidance on Co-Development of Therapeutics and Companion Diagnostics

IDDI WEBINAR: The Future of Cancer Clinical TrialsПодробнее

IDDI WEBINAR: The Future of Cancer Clinical Trials

The biomarker to companion diagnostic continuum a road map for the delivery of precision medicineПодробнее

The biomarker to companion diagnostic continuum a road map for the delivery of precision medicine

Current applications and future innovations for somatic testing in oncology careПодробнее

Current applications and future innovations for somatic testing in oncology care

Janice Au-Young - Companion Diagnostics Co-Development: Are you ready?Подробнее

Janice Au-Young - Companion Diagnostics Co-Development: Are you ready?

Biomarker Based Companion Diagnostics Are Enabling Precision OncologyПодробнее

Biomarker Based Companion Diagnostics Are Enabling Precision Oncology

Policy Forum: Building a National Companion Diagnostics Testing FrameworkПодробнее

Policy Forum: Building a National Companion Diagnostics Testing Framework

Global Policy Webinar: Growing Role of Patient Advocates in Cancer Research & Clinical Trial DesignПодробнее

Global Policy Webinar: Growing Role of Patient Advocates in Cancer Research & Clinical Trial Design